Alkermes plc is a biopharmaceutical company that develops innovative medicines to treat diseases related to the central nervous system. With a focus on addiction and mental health, their research and development efforts are aimed at addressing unmet medical needs and improving patient outcomes. With a diverse portfolio of products, Alkermes is committed to making a positive impact on the lives of those with these challenging conditions.
